EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Peak Bio's enterprise value is $8.47 Mil.
Peak Bio's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $0.61 Mil. Therefore, Peak Bio's EV-to-Revenue for today is 13.93.
The historical rank and industry rank for Peak Bio's EV-to-Revenue or its related term are showing as below:
PKBO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 13.68 Med: 31.53 Max: 298.07
Current: 13.93
During the past 2 years, the highest EV-to-Revenue of Peak Bio was 298.07. The lowest was 13.68. And the median was 31.53.
PKBO's EV-to-Revenue is ranked worse than 61.29% of 1041
companies
in the Biotechnology industry
Industry Median: 8.07
vs PKBO: 13.93
As of today (2024-05-16), Peak Bio's stock price is $0.0086.
Peak Bio's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.03. Therefore, Peak Bio's PS Ratio for today is 0.28.
Peak Bio EV-to-Revenue Historical Data
The historical data trend for Peak Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Peak Bio's EV-to-Revenue
For the Biotechnology subindustry, Peak Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peak Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Peak Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Peak Bio's EV-to-Revenue falls into.
Peak Bio's current Enterprise Value is $8.47 Mil.
Peak Bio's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peak Bio's share price for today is $0.0086.
Peak Bio's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peak Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Peak Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Peak Bio Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics addressing unmet needs in the areas of oncology and inflammation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PKBO has been successfully added to your